Roth Capital analyst Craig Irwin weighed in with a favorable report on shares of Pacific Ethanol Inc (NASDAQ:PEIX), after the ethanol maker released its second-quarter results, …
Mast Therapeutics Inc (NYSEMKT:MSTX) just announced to frustrated investors that EPIC results for its Sickle Cell pipeline drug vepoloxamer are pushed back now …
Roth Capital analyst Chris Lewis remains neutral on molecular diagnostics company EXACT Sciences Corporation (NASDAQ:EXAS). Following solid second quarter earnings results, but with …
Roth Capital analyst Craig Irwin weighs in Ballard Power Systems, Inc. (NASDAQ:BLDP), as the fuel cell maker is scheduled to report second-quarter results before market on Wed.
Roth Capital analyst Darren Aftahi weighs in on Glu Mobile Inc. (NASDAQ:GLUU) ahead of the company’s second-quarter earnings report on Tuesday, August 2.
Analyst Gerry Sweeney from Roth Capital affirmed Hudson Technologies, Inc. (NASDAQ:HDSN) with a Buy rating and price target of $6.
Roth Capital analyst Joseph Pantginis was out today with a research note on Peregrine Pharmaceuticals (NASDAQ:PPHM), after the drug-maker announced financial results for the fourth …
What does the future hold for Mast Therapeutics Inc (NYSEMKT:MSTX)? Roth Capital analyst Michael Higgins weighs in on the biotech company, providing investors a summary …
In a research report issued Tuesday, Roth Capital analyst Matt Koranda reiterated a Neutral rating on shares of Clean Diesel Technologies, Inc. (NASDAQ:CDTI) with …
Healthcare analysts provide their insights on Endo International plc – Ordinary Shares (NASDAQ:ENDP) and Cytokinetics, Inc. (NASDAQ:CYTK) following a new patent and management …
